IRISanRaf

Sfoglia per Rivista  NEUROLOGICAL SCIENCES

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 12 a 31 di 41
Titolo Data di pubblicazione Autore(i) File
Early (<= 1-h) vs. late (> 1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study 1-gen-2015 Allais, G; Bussone, G; Tullo, V; Cortelli, P; Valguarnera, F; Barbanti, P; Sette, G; Frediani, F; D'Arrigo, G; D'Onofrio, F; Comi, G; Curone, M; Colombo, B; Omboni, S; Benedetto, C
Effectiveness of an herbaceous derivatives, PHGG, plus sodium hyaluronate in the treatment of chronic constipation in patients with Parkinson's disease: a pilot study 1-gen-2022 Vacca, Laura; Proietti, Stefania; Bravi, Daniele; Radicati, Fabiana Giada; Stocchi, Fabrizio
Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura 1-gen-2014 Allais, G; Tullo, V; Cortelli, P; Barbanti, P; Valguarnera, F; Sette, G; D'Onofrio, F; Curone, M; Zava, D; Pezzola, D; Reggiardo, G; Omboni, S; Frediani, F; Bussone, G; Benedetto, C
Efficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studies 1-gen-2013 Tullo, V; Bussone, G; Omboni, S; Barbanti, P; Cortelli, P; Curone, M; Peccarisi, C; Benedetto, C; Pezzola, D; Zava, D; Allais, G
Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms 1-gen-2001 Vanacore, N; Bonifati, V; Fabbrini, G; Colosimo, C; De Michele, G; Marconi, R; Nicholl, D; Locuratolo, N; Talarico, G; Romano, S; Stocchi, F; Bonuccelli, U; De Mari, M; Vieregge, P; Meco, G; European Study Group on Atypical Parkinsonism, (ESGAP).
Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms 1-gen-2001 Vanacore, N; Bonifati, V; Colosimo, C; Fabbrini, G; De Michele, G; Marconi, R; Nicholl, D; Locuratolo, N; Romano, S; Talarico, G; Stocchi, F; Bonuccelli, U; Lamberti, P; Vieregge, P; Meco, G; European Study Group on Atypical Parkinsonism, (ESGAP).
Establishment of a biorepository for migraine research: the experience of interinstitutional multidisciplinary biobank (biobim) 1-gen-2011 Guadagni, F; Palmirotta, R; Ludovici, G; De Marchis, Ml; Savonarola, A; Leone, B; Spila, A; Somma, P; Egeo, G; Aurilia, C; Fofi, L; Barbanti, P
Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM) 1-gen-2013 Palmirotta, R; Barbanti, P; Ludovici, G; Egeo, G; Aurilia, C; Fofi, L; De Marchis, Ml; Spila, A; Ferroni, P; Della-Morte, D; Guadagni, F
Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatment 1-gen-2003 Fabbrini, G; Barbanti, P; Aurilia, C; Pauletti, C; Vanacore, N; Meco, G
Exploring depression in Alzheimer's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and management 1-gen-2023 Padovani, Alessandro; Antonini, Angelo; Barone, Paolo; Bellelli, Giuseppe; Fagiolini, Andrea; Ferini Strambi, Luigi; Sorbi, Sandro; Stocchi, Fabrizio
The first report of the Italian Migraine Registry (I-GRAINE) 1-gen-2022 Barbanti, Piero; Egeo, Gabriella; Aurilia, Cinzia; Fiorentini, Giulia; Proietti, Stefania; Tomino, Carlo; Bonassi, Stefano
Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders 1-gen-2012 Marconi, R; Antonini, A; Barone, P; Colosimo, C; Avarello, Tp; Bottacchi, E; Cannas, A; Ceravolo, Mg; Ceravolo, R; Cicarelli, G; Gaglio, Rm; Giglia, L; Iemolo, F; Manfredi, M; Meco, G; Nicoletti, A; Pederzoli, M; Petrone, A; Pisani, A; Pontieri, Fe; Quatrale, R; Ramat, S; Scala, R; Volpe, G; Zappulla, S; Bentivoglio, Ar; Stocchi, F; Trianni, G; Del Dotto, P; De Gaspari, D; Grasso, L; Morgante, F; Santangelo, G; Fabbrini, G; Morgante, L; PRIAMO study, Group
Future trends in drugs for migraine prophylaxis 1-gen-2012 Barbanti, P; Aurilia, C; Egeo, G; Fofi, L
Hypertension as a risk factor for migraine chronification 1-gen-2010 Barbanti, P; Aurilia, C; Egeo, G; Fofi, L
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 1-gen-2020 Altamura, C; Cevoli, S; Aurilia, C; Egeo, G; Fofi, L; Torelli, P; Brunelli, N; Pierangeli, G; Favoni, V; Fallacara, A; Pensato, U; Barbanti, P; Vernieri, F.
Migraine and movement disorders 1-gen-2012 D'Onofrio, F; Barbanti, P; Petretta, V; Casucci, G; Mazzeo, A; Lecce, B; Mundi, C; Cologno, D
Migraine prophylaxis: what is new and what we need? 1-gen-2011 Barbanti, P; Aurilia, C; Egeo, G; Fofi, L
Migraineurs' psychological traits do not influence response to erenumab 1-gen-2020 Altamura, C; Costa, C; Fofi, L; Viticchi, G; Fallacara, A; Brunelli, N; Egeo, G; Aurilia, C; Migliore, S; Barbanti, P; Silvestrini, M; Vernieri, F.
Modification of respiratory function parameters in patients with severe Parkinson's disease 1-gen-2002 De Pandis, Mf; Starace, A; Stefanelli, F; Marruzzo, P; Meoli, I; De Simone, G; Prati, R; Stocchi, F
Multiple sclerosis: pharmacogenomics and personalised drug treatment 1-gen-2006 V, Annibali; G, Ristori; S, Cannoni; S, Romano; A, Visconti; A, Ghazaryan; L, FIGÀ TALAMANCA; M, Salvetti; Mechelli, R.
Mostrati risultati da 12 a 31 di 41
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile